AWM
ARKG icon

Abound Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Abound Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-104
Closed -$2.75K – 1378
2026
Q1 		$2.75K Hold
104
– – ﹤0.01% 854
2025
Q4 		$3.01K Buy
+104
New +$3.12K ﹤0.01% 783
2024
Q4 		– Sell
-2
Closed -$52 – 1233
2024
Q3 		$52 Buy
+2
New +$51 ﹤0.01% 1293

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Abound Wealth Management's ARKG Position: Q2 2026 in Review

Abound Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 104 shares — an estimated $2.75K sold.

Abound Wealth Management first reported a position in ARKG in Q3 2024 and held it in 3 quarters. The position peaked at $3.01K in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Abound Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Abound Wealth Management sold 104 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.75K.
  • Abound Wealth Management first reported a position in ARK Genomic Revolution ETF in Q3 2024 and held it in 3 quarters.
  • Abound Wealth Management's ARK Genomic Revolution ETF position peaked at $3.01K in Q4 2025.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.